Overview

• Fabtech, a biopharma engineering company, opened subscriptions for Sept 29–Oct 1 at a Rs 181–191 band with 75-share lots, implying a Rs 14,325 minimum at the top end.
• The all-fresh issue totals about 1.21 crore shares (Rs 230.35 crore) with a 50% QIB, 15% NII and 35% retail allocation.
• Allotment is slated for Oct 3, refunds and demat credits are expected on Oct 6 and the listing is planned on BSE and NSE on Oct 7.
• Proceeds are earmarked for working capital requirements, inorganic growth through acquisitions and general corporate purposes.
• Grey-market indications were about Rs 20 this morning, suggesting only tentative gains, and such quotes are unofficial and volatile.